PAIT-survey-Prevalence of albuminuria in patients with diabetes and hypertension in Turkey
PRIMARY CARE DIABETES, vol.12, no.6, pp.558-564, 2018 (SCI-Expanded)
- Publication Type: Article / Article
- Volume: 12 Issue: 6
- Publication Date: 2018
- Doi Number: 10.1016/j.pcd.2018.08.008
- Journal Name: PRIMARY CARE DIABETES
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED)
- Page Numbers: pp.558-564
- Keywords: Albuminuria, Diabetes, Hypertension, RAAS inhibitors, CHRONIC KIDNEY-DISEASE, GLOMERULAR-FILTRATION-RATE, CARDIOVASCULAR RISK-FACTORS, COLLABORATIVE METAANALYSIS, GLUCOSE CONTROL, BLOOD-PRESSURE, RENAL-DISEASE, MICROALBUMINURIA, POPULATION, OUTCOMES
- Istanbul University Affiliated: No
Abstract
Background: Albuminuria is an early marker of kidney disease in patients with diabetes and/or hypertension undetected or untreated albuminuria is a leading cause of chronic kidney disease and cardiovascular events, The purpose of the present survey was to assess the prevalence of albuminuria in patients with diabetes and hypertension, treated with a combinations of renin angiotensin aldosterone system inhibitors and dihydropyridine calcium channel blockers.